China requires local clinical trial data for most Class II and III medical devices. Here's what foreign manufacturers need to know about timeline, cost, and GCP compliance in 2026.
China's volume-based procurement program now covers 12 categories of medical devices. Here's how foreign manufacturers can participate, price competitively, and protect margins.
Foreign medical device manufacturers can register with China's NMPA through 3 pathways. Compare timelines, costs, and requirements for Class I, II, and III devices.
China's new circular-economy plan targets an 8 trillion yuan recycling industry by 2030 with mandatory recycled-content rules. Here is how foreign companies can access the equipment, technology, and partnership opportunities.
China will begin phasing out the NEV purchase tax exemption from January 2027. Here is the timeline, the price-tier impact, and the pricing strategy adjustments foreign automakers need to make now.
The Guangzhou Futures Exchange opened lithium carbonate futures to overseas traders on July 3, 2026. Here is what direct access to China's lithium pricing means for your battery and EV supply chain strategy.